Premature ventricular complexes & PVC-induced cardiomyopathy
Ventricular ectopy burden · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Frequent premature ventricular complexes are usually benign but a high burden (often >10-15% of beats) can cause a reversible cardiomyopathy. Management stratifies by symptoms, PVC burden, morphology and underlying structural disease.
Red flags
- Syncope or pre-syncope with ectopy
- Falling LV ejection fraction on surveillance
- Multiform or very high-burden ectopy
- Exercise-induced ventricular arrhythmia
- Family history of sudden cardiac death
Assessment
Differential diagnosis
- Benign idiopathic PVCs (RVOT/LVOT origin)
- PVCs from structural heart disease
- Non-sustained VT
- Electrolyte-driven ectopy
- Ischaemia-related ectopy
- Catecholaminergic or inherited arrhythmia
Investigations
- 12-lead ECG (PVC morphology, QT)
- 24-48 hour Holter to quantify PVC burden
- Echocardiogram for LV function and structure
- Electrolytes including potassium and magnesium
- Exercise test if exertional symptoms
- Cardiac MRI if structural disease or scar suspected
Management
- Quantify PVC burden over 24-48 hours and characterise morphology
- Assess for underlying structural or ischaemic heart disease
- Correct electrolyte abnormalities and reduce stimulants/caffeine/alcohol
- Reassure patients with low burden, normal heart and tolerable symptoms
- Treat symptoms with a beta-blocker or non-dihydropyridine calcium blocker first-line
- Monitor LV function when burden exceeds ~10-15%
- Add or switch to an antiarrhythmic (flecainide if no structural disease, or amiodarone) if needed
- Refer for catheter ablation if high burden with cardiomyopathy or drug-refractory symptoms
- Re-echo after burden reduction to confirm recovery of LV function
- Investigate multiform or exertional PVCs for inherited/structural disease
- Address reversible triggers at each review
- Follow up with repeat Holter to document burden reduction
Drugs & doses
Bisoprolol 2.5-10 mg PO OD (or metoprolol 25-100 mg BD)
Verapamil SR 120-240 mg PO OD (if EF preserved)
Flecainide 50-150 mg PO BD (structurally normal heart only)
Amiodarone 200 mg PO OD maintenance (after loading) if other agents fail
Correct magnesium/potassium as needed
Disposition
Outpatient cardiology; electrophysiology referral for high-burden or drug-refractory cases with cardiomyopathy.
Complications & pitfalls
- PVC-induced cardiomyopathy
- Progression to sustained VT (with structural disease)
- Antiarrhythmic proarrhythmia
- Reduced quality of life from symptoms
- Missed underlying structural disease
Exam pearls
- A PVC burden above ~10-15% warrants LV surveillance for reversible cardiomyopathy
- RVOT PVCs (LBBB, inferior axis) in a normal heart are typically benign and ablatable
- Ablation can fully reverse PVC-induced cardiomyopathy
- Reassurance often suffices for low-burden symptomatic ectopy
- Multiform PVCs or those with structural disease deserve closer evaluation
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.